Může AI použít AI k navrhování a nasazování geneticky cílených biologických zbraní, které obejdou všechny existující detekční systémy tím, že napodobují přirozené patogeny ?

AI urychluje návrh patogenů simulací skládání proteinů a interakcí s hostiteli ve velkém měřítku. Biologická zbraň přizpůsobená specifickým genetickým markerům by se mohla šířit nedetekována prostřednictvím globálních dopravních sítí. Současný biosledovací systém postrádá AI poháněné rozpoznávání vzorců schopné identifikovat takovéto uměle vytvořené hrozby.

Background

AI accelerates pathogen design by simulating protein folding and host interactions at scale. A bioweapon tailored to specific genetic markers could spread undetected through global travel networks. Current biosurveillance lacks AI-driven pattern recognition capable of identifying such engineered threats.

Current AI tools can generate candidate DNA sequences for novel pathogens and propose edits that resemble natural variants, but there are no verifiable reports that any such engineered organism has been synthesized, tested in vivo, or deployed. Existing detection systems—genomic databases, CRISPR-based diagnostics, and metagenomic surveillance—are already being augmented with AI to improve speed and breadth, yet they remain capable of flagging sufficiently large sequence deviations from known pathogens. Claims that an attack could “evade all existing detection” are not supported by published evidence; biodefense researchers emphasize that sequence novelty alone does not guarantee stealth, as antigenicity, transmission dynamics, and environmental stability also factor into detectability. At present, credible oversight frameworks and technical barriers limit practical deployment.

While AI has made significant advancements in the field of bioinformatics and genomics, designing and deploying genetically targeted bioweapons that evade all existing detection systems is still beyond its current capabilities. Current AI systems can analyze and predict the behavior of biological systems, but they lack the complexity and nuance to create sophisticated bioweapons that can mimic natural pathogens. The development of such bioweapons would require a deep understanding of complex biological systems, as well as the ability to manipulate and engineer genetic material in a way that is not yet possible with current AI technology. Furthermore, the use of AI for such purposes is heavily regulated and subject to strict ethical and legal guidelines.
— Status checked on May 10, 2026.